🔴 Major arrhythmias in non-dilated LV cardiomyopathy: a novel prediction score European Society of Cardiology Journals #Cardiology #Cardioed Bettina Heidecker

Aspirin, cardiovascular events, and major bleeding in older adults: extended follow-up of the ASPREE trial: European Society of Cardiology Journals 🥸Aspirin for primary prevention for older pts = MACE! 👇👇👇👇

Midventricular obstruction occurs in approximately 9.4% of patients with HCM. Read our JASE report, "Distance Between the Anterior Papillary Muscle and Interventricular Septum Evaluated by Echo to Diagnose Midventricular Obstruction in HCM." bit.ly/3Htpkxd

Atrial cardiomyopathy: a journey from healthy atria to atrial failure. Check out the new clinical consensus statement by the #HFA #EJHF. Essential read for cardiology! #AtrialCardiomyopathy ow.ly/2o2x50WEwbe EJHF Editor-in-Chief Amr Abdin Giuseppe Galati Henry Han

Aficamten vs Metoprolol for Obstructive Hypertrophic Cardiomyopathy: MAPLE-HCM Rationale, Study Design, and Baseline Characteristics Beta-blockers remain first-line therapy for symptomatic oHCM despite limited evidence. MAPLE-HCM: phase 3 trial comparing aficamten vs metoprolol

🧵 2025 AHA Hypertension Guidelines: Changes & New Updates 1/ The 2025 AHA/ACC hypertension guideline replaces the 2017 version with key, evidence-driven changes. Here are the must-know updates for your clinical practice. Dr Ihab Suliman Dr. Akhil 🇮🇳 CardiovascularCorner Dr Sumer Sethi

Recurrent Events Analysis of MASTER DAPT: Total Ischemic and Bleeding Events After Abbreviated vs Prolonged DAPT in HBR Patients A 1-month DAPT duration was associated with similar total NACEs and MACCEs and reduced total bleeding risk compared with prolonged DAPT

Early detection = better prevention. 🫀 Identifying & managing high-risk patients is key to stopping CVD before it starts. 👉 sciencedirect.com/science/articl… #HeartHealth #CardioPrevention

🚨 AI won’t replace doctors… but it can prevent them from learning how to think. A critical article in NEJM shows that if introduced too early in medical training, it weakens clinical reasoning. ✅ A good doctor will always need critical thinking. N Engl J Med 2025;393:786

What are factors associated with disease onset in Titin-related familial dilated cardiomyopathy? Read more in #EHJ 👉 ow.ly/ha7850WIQ4b Rocco Montone EHJ Editor-in-Chief

Sex-specific body fat distribution predicts cardiovascular ageing: European Society of Cardiology Journals 🥸 Cardiovascular #Aging and imaging! 👇👇👇

Over 1 billion people live with obesity. There is an urgent need for a universal definition and diagnosis. A The Lancet Diabetes & Endocrinology Commission introduces a new model with categories: clinical obesity (an illness) and pre-clinical obesity. Read now ➡️ hubs.li/Q03DztnS0

The #ESCCongress is the perfect stage to share the date of the next #RomaCMP 🗓️ 23-24 Oct 2026 📍Rome 👩🏻‍⚕️ X 5️⃣ Cristina Chimenti beamusumeci Chiaralanzillo francesca graziani_FG #FedericaRe 🔐Mark your calendar and stay tuned

🚀 REBOOT-CNIC and BETAMI-DANBLOCK trials report discordant evidence on the role of beta-blockers in post-MI patients with LVEF >40%. An IPD meta-analysis suggests treatment benefit in those with LVEF 40-49%. What’s your take? #Pharmacotherapy #ESCCongress 📢 European Society of Cardiology 📡

#ESCCongress GENETIC MATTERS! Fernando Domínguez on genetic testing in #myocarditis 🧬 family hx of cardiomyopathies/ 'familial myocarditis' 🧬 high-risk CMR patterns -💍like pattern/septal LGE 🧬 recurrent episodes 🧬 severe episodes / slow recovery ❗️8% of cases w/ genetic background!!

🔴 Guidelines for the Standardization of Adult Echocardiography Reporting: Recommendations From American Society of Echocardiography #Echofirst #Cardiology #Cardioed

New The Lancet Meta-Analysis by #NelsonWang Brigham and Women's Hospital HF Fellow What is the expected BP lowering with various antihypertensive regimens? Robust model derived from n=104,176 pts across 484 RCTs Terrific user-friendly tool: bpmodel.org thelancet.com/journals/lance…

A beautiful "explainer" of everything a cardiologist needs to know about #eGFR in HF clinical practice with modern #GDMT ...and a plug to bring back #eGFRslope as an endpoint in HF clinical trials New in #EHJ with leading nephrologists Brendon Neuen academic.oup.com/eurheartj/adva…

Advancements in Lipid-Lowering Therapies: Targeting Key Mechanisms in Lipid and Lipoprotein Metabolism! Read the news in #EHJ! academic.oup.com/eurheartj/adva… #lipoproteins #EHJ #cardiotwitter @ESC_journals European Society of Cardiology

New online! The prevention of adult cardiovascular disease must begin in childhood: evidence and imperative nature.com/articles/s4156…